VivoSense is the world leader in data analysis consulting and software, specializing in wearable sensor physiological monitoring solutions for clinical trials, healthcare research, and consumer wellness. VivoSense develops regulatory compliant digital biomarkers using the data from wearable sensors. Digital biomarkers are used to accurately measure drug and treatment effects in patients in regulated clinical trials and healthcare research. VivoSense is the first analytics company to develop novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials. Several of these studies are in rare disease indication and have reached the open-label phase of development at top-ten pharma.